Legend Biotech Ownership | Who Owns Legend Biotech?
Legend Biotech Ownership Summary
Legend Biotech is owned by 28.35% institutional investors, 1.32% insiders, and 70.33% retail investors. Fmr is the largest institutional shareholder, holding 7.36% of LEGN shares. Invesco Emerging Markets Equity is the top mutual fund, with 1.62% of its assets in Legend Biotech shares.
LEGN Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | Legend Biotech | 28.35% | 1.32% | 70.33% |
Sector | Healthcare Stocks | 57.39% | 9.93% | 32.68% |
Industry | Biotech Stocks | 68.48% | 9.65% | 21.87% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
Holder | Shares | % Holding | Value |
---|---|---|---|
Fmr | 13.45M | 7.36% | $437.57M |
Ra capital management | 7.51M | 4.11% | $244.28M |
Price t rowe associates inc /md/ | 6.81M | 3.73% | $221.53M |
Hhlr advisors | 5.98M | 3.28% | $194.74M |
Blackrock | 5.72M | 3.14% | $253.40M |
Westfield capital management co lp | 5.71M | 3.13% | $185.92M |
Blackrock funding, inc. /de | 4.61M | 2.52% | $149.96M |
Suvretta capital management | 3.50M | 1.91% | $113.77M |
Invesco | 3.31M | 1.81% | $107.71M |
Braidwell lp | 2.98M | 1.63% | $96.90M |
Top Institutional Shareholders by % of Total Assets
Holder | Shares | % Assets | Value |
---|---|---|---|
Matthews capital management | 1.19M | 7.89% | $38.58M |
Johnson & johnson | 814.59K | 6.86% | $26.51M |
Hhlr advisors | 5.98M | 6.74% | $194.74M |
Suvretta capital management | 3.50M | 3.88% | $113.77M |
Ivyrock asset management (hk) | 267.10K | 3.84% | $8.69M |
Ra capital management | 7.51M | 3.25% | $244.28M |
Braidwell lp | 2.98M | 2.87% | $96.90M |
Tri locum partners lp | 388.70K | 2.62% | $12.65M |
Superstring capital management lp | 69.59K | 1.96% | $2.26M |
Tiger pacific capital lp | 222.00K | 1.93% | $7.22M |
Top Buyers
Holder | Shares | % Assets | Change |
---|---|---|---|
Suvretta capital management | 3.50M | 3.88% | 3.50M |
Goldman sachs group | 2.49M | 0.01% | 2.04M |
Deerfield management company, l.p. (series c) | 1.55M | 0.96% | 1.55M |
Braidwell lp | 2.98M | 2.87% | 1.44M |
Invesco | 3.31M | 0.02% | 1.02M |
Top Sellers
Holder | Shares | % Assets | Change |
---|---|---|---|
Fmr | 13.45M | 0.03% | -4.88M |
Price t rowe associates inc /md/ | 6.81M | 0.03% | -4.36M |
Capital world investors | - | - | -2.39M |
Paradigm biocapital advisors lp | - | - | -1.20M |
Timessquare capital management | 2.91K | 0.00% | -1.16M |
New Positions
Holder | Shares | % Assets | Change | Value |
---|---|---|---|---|
Suvretta capital management | 3.50M | 3.88% | 3.50M | $113.77M |
Deerfield management company, l.p. (series c) | 1.55M | 0.96% | 1.55M | $50.49M |
Tang capital management | 450.00K | 0.97% | 450.00K | $14.64M |
Bnp paribas arbitrage, snc | 243.99K | 0.00% | 243.99K | $7.94M |
Los angeles capital management | 172.44K | 0.02% | 172.44K | $5.61M |
Sold Out
Holder | Change |
---|---|
Smartleaf asset management | -21.00 |
Macroview investment management | -36.00 |
Peak6 investments | -200.00 |
Lazard asset management | -380.00 |
Allspring global investments | -485.00 |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Dec 31, 2024 | 138 | -36.41% | 51,770,843 | -43.26% | 28 | 1.14% | 79 | -31.90% | 38 | -39.68% |
Sep 30, 2024 | 217 | 14.81% | 91,247,449 | -0.49% | 49 | 1.98% | 116 | 5.45% | 63 | 31.25% |
Jun 30, 2024 | 186 | -11.85% | 91,687,379 | 5.90% | 50 | 2.08% | 107 | -5.31% | 48 | -23.81% |
Mar 31, 2024 | 211 | -7.05% | 86,578,276 | 0.79% | 49 | 8.08% | 113 | -13.08% | 63 | 6.78% |
Dec 31, 2023 | 227 | 5.09% | 85,900,395 | -0.06% | 24 | 1.03% | 130 | 36.84% | 59 | -16.90% |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
Invesco Emerging Markets Equity | 2.96M | 1.62% | 929.05K |
Fidelity Select Health Care | 2.80M | 1.52% | - |
Invesco Developing Markets A | 2.70M | 1.47% | -266.36K |
Fidelity Growth Compy Commingled Pl O | 2.43M | 1.32% | - |
T. Rowe Price US Growth Stock Composite | 2.32M | 1.26% | -77.22K |
T. Rowe Price Growth Stock | 2.27M | 1.24% | -32.51K |
Fidelity Advisor Health Care I | 1.67M | 0.91% | - |
MFS Mid Cap Growth Equity | 1.58M | 0.86% | 15.32K |
MFS Mid Cap Growth A | 1.56M | 0.85% | -10.13K |
T. Rowe Price US Large-Cap Growth Equity | 1.48M | 0.81% | -8.75K |
LEGN Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools